AnaptysBio, Inc.ANABNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+11.5%
5Y CAGR+21.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+11.5%/yr
vs +23.9%/yr prior
5Y CAGR
+21.9%/yr
Recent deceleration
Acceleration
-12.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $50.74M | +19.7% |
| 2024 | $42.39M | +1.1% |
| 2023 | $41.95M | +14.5% |
| 2022 | $36.64M | +70.5% |
| 2021 | $21.49M | +14.0% |
| 2020 | $18.85M | +17.1% |
| 2019 | $16.09M | +3.7% |
| 2018 | $15.53M | +66.3% |
| 2017 | $9.34M | +117.7% |
| 2016 | $4.29M | - |